Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | TTR | P02766 | 1/20 | 0.43 |
| ▸ | PPOX | P50336 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | PYGL | P06737 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fomesafen SCHEMBL7581201 | 0.94 | MEN1 (0.36) | MEN1KMT2ATTRPPOXTDP1 | |
| Oxyfluorfen SCHEMBL7588965 | 0.94 | MEN1 (0.35) | MEN1KMT2ATTRPPOXTDP1 | |
| Isoxaflutole SCHEMBL7585871 | 0.94 | MEN1 (0.38) | MEN1KMT2ATTRPPOXTDP1 | |
| Lactofen SCHEMBL7578359 | 0.93 | TDP1 (0.35) | MEN1KMT2ATTRPPOXTDP1 | |
| Isoxaflutole SCHEMBL7577835 | 0.93 | TDP1 (0.35) | MEN1KMT2ATTRPPOXTDP1 | |
| Isoxaflutole SCHEMBL7578161 | 0.93 | TDP1 (0.39) | MEN1KMT2ATTRPPOXTDP1 | |
| Isoxaflutole SCHEMBL7582314 | 0.93 | MEN1 (0.37) | MEN1KMT2ATTRPPOXTDP1 | |
| Isoxaflutole SCHEMBL7585172 | 0.92 | MEN1 (0.36) | MEN1KMT2ATTRPPOXTDP1 | |
| Fomesafen SCHEMBL7583065 | 0.90 | MEN1 (0.33) | MEN1KMT2ATTRPPOXTDP1 | |
| Isoxaflutole SCHEMBL7582526 | 0.89 | MEN1 (0.32) | MEN1KMT2ATTRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | SYNGENTA PARTICIPATIONS AG (CH) | 2002-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | PPOX, ALAD, DDT | MEN1 4274/4885KMT2A 2099/4885TTR 1945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.